Buruli ulcer

Technical groups

WHO Technical Advisory Group (TAG) on Buruli ulcer

The WHO Technical Advisory Group on Buruli ulcer meets once a year and is composed of 16 members who are chosen for their expertise in Buruli ulcer control and research. Members serve for a period of 3 years and may be reappointed. TAG members are expected to:

  • monitor the implementation of the intensified control strategy;
  • promote research according to agreed priorities;
  • identify obstacles for the effective control of Buruli ulcer and recommend corrective actions;
  • advise on and prioritize new research initiatives;
  • ensure impartial review of new research proposals;
  • promote awareness of Buruli ulcer in the context of neglected tropical diseases;
  • assist in identifying funding to support the implementation of the above-mentioned activities.

Final report of the Technical Advisory Group (TAG) on Buruli ulcer, 2009.

Working Groups

During the Annual Meeting on Buruli ulcer disease which took place at WHO headquarters in Geneva, Switzerland from 22–24 March 2010, 6 WHO Working Groups were established.

The main aim is to accelerate the implementation of the 2009 Cotonou Declaration on Buruli ulcer disease.

The Working Groups are also expected to create conditions for the promotion of international cooperation to tackle the problems associated with Buruli ulcer disease.

The 6 Working Groups are:

  • Strategy implementation and coordination
  • Care and support
  • Laboratory support network
  • Drug treatment
  • Epidemiology and surveillance
  • Research

Buruli in the news!

19 November 2015 | Geneva
New research shows the diagnostic potential of fluorescent thin layer chromatography to detect mycolactone in Buruli ulcer


12 November 2015 | Geneva
Despite limitations, clinical practice and observational data are allowing acquisition of knowledge - crucial to informing international guidance for Buruli ulcer disease management


30 September 2015 | Geneva
Rapid diagnosis of Buruli ulcer now possible at district-level health facilities


05 March 2015 | Geneva
Management of Buruli ulcer–HIV coinfection – Technical update
Ref: WHO/HTM/NTD/IDM/2015.01


10 facts on Buruli ulcer
Read the 10 facts


Laboratory confirmation
Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease)